Anti-mullerian hormone is higher in seizure-free women with epilepsy compared to those with ongoing seizures

被引:7
|
作者
Harden, Cynthia L. [1 ]
Pennell, Page B. [2 ]
French, Jacqueline A. [3 ]
Davis, Anne [4 ]
Lau, Connie [5 ]
Llewellyn, Nichelle [2 ]
Kaufman, Benjamin [3 ]
Bagiella, Emilia [1 ]
Kirshenbaum, Ariel [2 ]
机构
[1] Icahn Sch Med Mt Sinai, 1428 Madison Ave, New York, NY 11029 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] NYU, Sch Med, 462 1st Ave, New York, NY 10016 USA
[4] Columbia Univ, Med Ctr, 630 W 168th St, New York, NY 10032 USA
[5] Northwell Hlth, 611 Northern Blvd, Great Neck, NY 11021 USA
基金
美国国家卫生研究院;
关键词
Seizures; Anti-mullerian hormone; AMH; Epilepsy; Ovarian reserve; MEN;
D O I
10.1016/j.eplepsyres.2016.08.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine if anti-mullerian hormone (AMH), a neuroactive peptide hormone and a measure of ovarian reserve, is different between women with epilepsy (WWE) and healthy controls (HC) seeking pregnancy and to evaluate epilepsy-related factors associated with AMH concentrations. Methods: Subjects were participants in Women with Epilepsy: Pregnancy Outcomes and Deliveries (WEPOD), a multi-center prospective, observational cohort study evaluating fecundity in WWE compared to HC, ages 18-40 years. WWE were divided into a Sz+ group or a Sz- group, dependent on whether they had seizures within the 9 months prior to enrollment. Serum was collected, and AMH concentrations were measured as an exploratory analysis. Linear and logistic regression models were used to assess associations and control for covariates. Results: Serum AMH concentrations were measured in 72 out of 90 enrolled WWE and 97 out of 109 HC; the remaining subjects became pregnant before serum was obtained. Thirty WWE were in the Sz+ group and 40 in the Sz- group (retrospective seizure information was missing for two). All AMH concentrations were within the range, however, the normal inverse correlation between age and AMH was present in the HC and in the Sz- groups, but was lacking in the Sz+ group. Mean AMH concentration was higher in the Sz- group (3982 pg/ml (SD +/-2452)) compared to the Sz+ group of WWE (2776 pg/ml (SD +/-2308)) and HCs (3241 (SD perpendicular to 2647)). All values were within the expected range for age. In WWE, by linear regression, after controlling for age and BMI, seizure occurrence remained associated with AMH (p = 0.025). In the prospective phase of the study, AMH concentrations were also associated with seizure occurrence during the menstrual cycle in which the serum sample was obtained (p = 0.012). Antiepileptic drugs and other epilepsy factors were not associated with AMH concentrations. When analyzing the Sz- WWE group and the HC group by linear regression with AMH as the dependent variable, after controlling for age and BMI, the association with AMH was also present (p = 0.017). AMH concentrations of the Sz+ group and HCs did not differ. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 50 条
  • [1] Serum anti-Mullerian hormone in subfertile women
    Somigliana, Edgardo
    Lattuada, Debora
    Colciaghi, Barbara
    Filippi, Francesca
    La Vecchia, Irene
    Tirelli, Amedea
    Baffero, Giulia M.
    Paffoni, Alessio
    Persico, Nicola
    Bolis, Giorgio
    Fedele, Luigi
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2015, 94 (12) : 1307 - 1312
  • [2] LOW ANTI-MULLERIAN HORMONE (AMH) IS A PREDICTOR OF HIGHER CLINICAL PREGNANCY PROBABILITY IN YOUNGER WOMEN COMPARED TO OLDER WOMEN.
    Mensah, V.
    Alvero, R.
    Zhang, Y.
    Huang, Y.
    Wang, S.
    FERTILITY AND STERILITY, 2016, 106 (03) : E123 - E123
  • [3] Late seizures in patients initially seizure-free after epilepsy surgery
    Schwartz, Theodore H.
    Bingaman, William E.
    Jeha, Lara
    Tanner, Adriana
    Sperling, Michael
    NEUROSURGERY, 2006, 59 (02) : 482 - 483
  • [4] Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures
    Fu, Yun-xing
    Yang, Hui-min
    OuYang, Xiao-e
    Hu, Rong
    Hu, Ting
    Wang, Fei-miao
    REPRODUCTIVE SCIENCES, 2021, 28 (02) : 406 - 415
  • [5] Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures
    Yun-xing Fu
    Hui-min Yang
    Xiao-e OuYang
    Rong Hu
    Ting Hu
    Fei-miao Wang
    Reproductive Sciences, 2021, 28 : 406 - 415
  • [6] Undetectable serum anti-Mullerian hormone levels and occurrence of ongoing pregnancy
    Fraisse, Timothee
    Ibecheole, Victoria
    Streuli, Isabelle
    Bischof, Paul
    de Ziegler, Dominique
    FERTILITY AND STERILITY, 2008, 89 (03) : 723.e9 - 723.e11
  • [7] Anti-Mullerian Hormone Levels and Risk of Cancer in Women
    Verdiesen, Renee M. G.
    van Gils, Carla H.
    Stellato, Rebecca K.
    Verschuren, W. M. Monique
    Broekmans, Frank J. M.
    de Kat, Annelien C.
    van der Schouw, Yvonne T.
    Onland-Moret, N. Charlotte
    MATURITAS, 2021, 143 : 216 - 222
  • [8] Clinical application of serum anti-Mullerian hormone in women
    Oh, So Ra
    Choe, Sun Yi
    Cho, Yeon Jean
    CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, 2019, 46 (02): : 50 - 59
  • [9] Reference intervals of anti-Mullerian hormone in Korean women
    Choi, Rihwa
    Lee, Sang Gon
    Lee, Eun Hee
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (09)
  • [10] Seizure-free outcome and safety of repeated epilepsy surgery for persistent or recurrent seizures
    Kunz, M.
    Karschnia, P.
    Borggraefe, I.
    Noachtar, S.
    Tonn, J. -C.
    Vollmar, C.
    EPILEPSIA, 2022, 63 : 185 - 185